Article Details
Retrieved on: 2022-09-23 10:32:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
After new phase 2b readout, and likely with an eye on rivals, AstraZeneca says it won't take Ionis' partnered PCSK9 inhibitor AZD8233 into a phase ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here